1. Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis
   Tahereh Zeinali et al, 2019, Biomedicine & Pharmacotherapy CrossRef
2. Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription
   Yanyan Li et al, 2018, Cell Death Dis CrossRef
3. null
   Shang-Hung Chen et al, 2018 CrossRef
4. Identification of a new tamoxifen-xanthene hybrid as pro-apoptotic anticancer agent
   Elena Catanzaro et al, 2019, Bioorganic Chemistry CrossRef
5. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study
   Marina Touillaud et al, 2019 CrossRef
6. TRIM2 is a novel promoter of human colorectal cancer
   Hua Cao et al, 2019, Scandinavian Journal of Gastroenterology CrossRef
7. Overexpression miR‐24‐3p repressed Bim expression to confer tamoxifen resistance in breast cancer
   Xu Han et al, 2019, J Cell Biochem CrossRef
8. miR‐205‐3p promotes proliferation and reduces apoptosis of breast cancer MCF‐7 cells and is associated with poor prognosis of breast cancer patients
   Changhong Qiu et al, 2019, J Clin Lab Anal CrossRef
9. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells
   Tenghua Yu et al, 2020, Molecular and Cellular Endocrinology CrossRef
10. Context-Specific Coordinately Regulatory Network Prioritize Breast Cancer Genetic Risk Factors
    Shuyuan Wang et al, 2020, Front. Genet. CrossRef
11. IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation
    Yan Zheng et al, 2020, Front. Endocrinol. CrossRef
12. p85β regulates autophagic degradation of AXL to activate oncogenic signaling
    Ling Rao et al, 2020, Nat Commun CrossRef
13. TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma
    Zhaoxian Lin et al, 2020, Cancer Cell Int CrossRef
14. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma
    Junfeng Deng et al, 2019, Mol Med Report CrossRef
15. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis.
    Qiqing Sun et al, 2020, Oncogene CrossRef
16. Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells
    Megumi Funakoshi-Tago et al, 2020, Sci Rep CrossRef
17. Nanotechnology-based drug delivery systems for the improved sensitization of tamoxifen
    Xuan Chao et al, 2020, Journal of Drug Delivery Science and Technology CrossRef
18. Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function
    Milad Rouhimoghadam et al, 2020, Front. Endocrinol. CrossRef
19. Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer.
    Jingwei Yao et al, 2020, Front Pharmacol CrossRef
20. G-Protein-Coupled Estrogen Receptor 1 Promotes Gender Disparities in Hepatocellular Carcinoma via Modulation of SIN1 and mTOR Complex 2 Activity.
    Guanying Feng et al, 2020, Mol Cancer Res CrossRef
21. Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors
    Anh S. Lu et al, 2021, Mol. Pharmaceutics CrossRef
22. GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma
    Yu-an Qiu et al, 2021, Front. Oncol. CrossRef
23. E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential
    Yuanqi Liu et al, 2021, Front. Pharmacol. CrossRef
24. The translational values of TRIM family in pan-cancers: from functions and mechanisms to clinics
    Guo Zhao et al, 2021, Pharmacology & Therapeutics CrossRef
25. Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers
    Mirco Masi et al, 2021, Cells CrossRef
26. Low concentrations of 17β‐estradiol exacerbate tamoxifen resistance in breast cancer treatment through membrane estrogen receptor‐mediated signaling pathways
    Zhixiang Xu et al, 2022, Environmental Toxicology CrossRef
27. LINC01535 Attenuates ccRCC Progression through Regulation of the miR-146b-5p/TRIM2 Axis and Inactivation of the PI3K/Akt Pathway
    Zhiming Zhang et al, 2022, Journal of Oncology CrossRef
28. Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis
    Zili Zhou et al, 2022, J Transl Med CrossRef
29. The roles of ubiquitination‐mediated intrinsic apoptotic signalling in cancer therapy
    Tiantian Che et al, 2022, Clinical and Translational Dis CrossRef
30. null
    Hong-Bing Zhang et al, 2022 CrossRef
31. Expression and Role of TRIM2 in Human Diseases
    Maolin Xiao et al, 2022, BioMed Research International CrossRef
32. Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer
    Chung-Liang Li et al, 2022, IJMS CrossRef
33. Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis
    Duo Zhang et al, 2022, Technol Cancer Res Treat CrossRef
34. TRIM family contribute to tumorigenesis, cancer development, and drug resistance
    Ning Huang et al, 2022, Exp Hematol Oncol CrossRef
35. The Predictive and Prognostic Role of RAS–RAF–MEK–ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets
    Andrea Rocca et al, 2022, Cancers CrossRef
36. Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE)
    Kun Qian et al, 2022, Invest New Drugs CrossRef
37. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells
    Yue Zhang et al, 2022, Oncogene CrossRef
38. TRIM proteins in breast cancer: Function and mechanism
    Xin Bai et al, 2022, Biochemical and Biophysical Research Communications CrossRef
39. null
    F. O. Andrade et al, 2019 CrossRef
40. The crosstalk between ubiquitination and endocrine therapy
    Yidong Ge et al, 2023, J Mol Med CrossRef
41. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1
    Xiaowei Fei et al, 2023, Exp Mol Med CrossRef
42. Characterization of Breast Cancer Aggressiveness by Cell Mechanics
    Barbara Zbiral et al, 2023, IJMS CrossRef